Your browser doesn't support javascript.
loading
[The Beneficial Effects of Switching from Dipeptidyl Peptidase-4 Inhibitors to Dulaglutide on Plasma Glucose and Hemoglobin A1c Levels: A Case Report of Four Patients with Type 2 Diabetes].
Shimoda, Kenichiro; Hoshino, Teruhiko; Morisaki, Takafumi; Shiotsu, Kazunori; Mizuno, Yuji.
Affiliation
  • Shimoda K; Department of Pharmacy, Kumamoto Kinoh Hospital.
  • Hoshino T; Department of Pharmacy, Kumamoto Kinoh Hospital.
  • Morisaki T; Department of Pharmacy, Kumamoto Kinoh Hospital.
  • Shiotsu K; Department of Pharmacy, Kumamoto Kinoh Hospital.
  • Mizuno Y; Division of Cardiovascular Medicine, Kumamoto Kinoh Hospital.
Yakugaku Zasshi ; 138(10): 1323-1327, 2018.
Article in Ja | MEDLINE | ID: mdl-30270278
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Recombinant Fusion Proteins / Glycated Hemoglobin / Immunoglobulin Fc Fragments / Diabetes Mellitus, Type 2 / Glucagon-Like Peptides / Dipeptidyl-Peptidase IV Inhibitors / Drug Substitution Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: Ja Journal: Yakugaku Zasshi Year: 2018 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Blood Glucose / Recombinant Fusion Proteins / Glycated Hemoglobin / Immunoglobulin Fc Fragments / Diabetes Mellitus, Type 2 / Glucagon-Like Peptides / Dipeptidyl-Peptidase IV Inhibitors / Drug Substitution Limits: Aged / Aged80 / Female / Humans / Male / Middle aged Language: Ja Journal: Yakugaku Zasshi Year: 2018 Document type: Article Country of publication: